Literature DB >> 9184132

The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.

V L Sampson1, J H Morrison, J C Vickers.   

Abstract

The vulnerability of nerve cells to the neurofibrillary pathology of Alzheimer's disease (AD) may be determined by the presence within them of certain cytoskeletal proteins. Fluorescence multiple labeling was used to assess the vulnerability of two separate subpopulations of nonpyramidal neurons in the superior frontal gyrus, distinguished by their content of the calcium-binding proteins parvalbumin (PV) and calretinin (CR), to the neuropathology of AD. In AD, counterstaining PV- and CR-labeled sections with thioflavine S demonstrated that the great majority of these cells did not contain neurofibrillary tangles, except for the large CR-immunoreactive neurons in layer I. This latter group of cells was also characterized as containing neurofilament (NF) triplet proteins, whereas other CR-labeled cortical neurons were not immunoreactive for NF. There was also a small AD-related increase in the proportion of PV-labeled cells showing NF protein immunoreactivity (1-9% of the total population in AD cases compared to 0-0.4% in non-AD cases), which likewise may be linked to the susceptibility of a minute proportion (0-0.7%) of these neurons to form neurofibrillary tangles in AD. These data are further evidence that the presence of NF in cortical nerve cells is linked to their vulnerability to the pathological process underlying AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184132     DOI: 10.1006/exnr.1997.6433

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

1.  Changes induced by natural scrapie in the calretinin-immunopositive cells and fibres of the sheep cerebellar cortex.

Authors:  Adolfo Toledano; María-Isabel Alvarez; Eva Monleón; Adolfo Toledano-Díaz; Juan-José Badiola; Marta Monzón
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.

Authors:  Farhan Ali; Stephanie L Baringer; Arianna Neal; Esther Y Choi; Alex C Kwan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Activity-dependent regulation of surface glucose transporter-3.

Authors:  Jainne M Ferreira; Arthur L Burnett; Gerald A Rameau
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

Review 4.  'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice.

Authors:  Beat Schwaller; Michael Meyer; Serge Schiffmann
Journal:  Cerebellum       Date:  2002-12       Impact factor: 3.847

5.  Posterior parahippocampal gyrus pathology in Alzheimer's disease.

Authors:  R Thangavel; G W Van Hoesen; A Zaheer
Journal:  Neuroscience       Date:  2008-04-08       Impact factor: 3.590

6.  Specific neuronal subpopulations in the amygdala of macaque monkeys express high levels of nonphosphorylated neurofilaments.

Authors:  Alexander Joseph McDonald; Alvaro Duque
Journal:  Brain Res       Date:  2021-12-24       Impact factor: 3.252

7.  Age-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer's disease.

Authors:  Marijke A M Lemmens; Annerieke S R Sierksma; Bart P F Rutten; Frank Dennissen; Harry W M Steinbusch; Paul J Lucassen; Christoph Schmitz
Journal:  Brain Struct Funct       Date:  2011-03-16       Impact factor: 3.270

8.  Specific neuronal subpopulations in the rat basolateral amygdala express high levels of nonphosphorylated neurofilaments.

Authors:  Alexander Joseph McDonald; Franco Mascagni
Journal:  J Comp Neurol       Date:  2021-05-14       Impact factor: 3.028

9.  Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models.

Authors:  Stanislaw Mitew; Matthew T K Kirkcaldie; Tracey C Dickson; James C Vickers
Journal:  Front Neuroanat       Date:  2013-09-26       Impact factor: 3.856

Review 10.  Defining the earliest pathological changes of Alzheimer's disease.

Authors:  James C Vickers; Stan Mitew; Adele Woodhouse; Carmen M Fernandez-Martos; Mathew T Kirkcaldie; Alison J Canty; Graeme H McCormack; Anna E King
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.